ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care

ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function...

GU Ventures AB

ZEISS and EDGE leverage AI to transform bioimaging in the biopharma industry

Transforming complex bioimaging data to workflows offering actionable insights for decision-making to speed up drug discovery.

Structured dialogue with SGS Fimko

What is Structured Dialogue?

Partner article: Building sponsor oversight for a pivotal Phase III program

OncoZenge is preparing to initiate a pivotal Phase III study for BupiZenge™, a treatment for oral mucositis pain in cancer patients. As the program advances int...

EDIH Summit 2026 Finalist: Simplifying Regulatory Compliance

Excited to be recognized as one of five European Digital Innovation Hub (EDIH) Community Award finalists at the EDIH Summit 2026!

Deepen your expertise with ZEISS Academy Metrology

Explore your individual learning path and expand your knowledge.

Aurevia expert spotlight: 3 questions with our risk management expert

Meet Cristina Albu Barkman, Principal Consultant, and one of Aurevia’s most experienced specialists in medical device risk management. With more than 25 years i...

AlzeCure Signs Billion-Dollar Deal with Lilly

AlzeCure, a Huddinge-based biotech company, has signed a licensing agreement with Eli Lilly for one of its Alzheimer’s drug candidates.

The Versatile Solution for Quality Management and Data Analysis

Join our ZEISS PiWeb webinar on March 26.

Dying man saved by artificial lung system

An external artificial lung system kept a critically ill man alive for two days until he could undergo a lung transplant. In the longer term, researchers hope t...

Takedas miljardköp inom psoriasis slog konkurrent i studie

Takedas orala läkemedelskandidat zasocitinib rapporteras visa klart bättre resultat än Bristol Myers Squibbs godkända motsvarighet Sotyktu i en head-to-head-stu...

5 reasons to choose Aurevia

In today’s complex life sciences landscape, success depends on working with a partner who understands both the regulatory environment and the realities of clinical research.

Thermo Fisher’s lab in Gothenburg opens

Thermo Fisher’s clinical research business, PPD, is opening its first bioanalytical laboratory in Europe. The company chose Gothenburg for the new facility, whi...

Germany strengthens medical data governance – what it means for life science

On 11 March 2026, the German Federal Cabinet adopted the draft Medical Register Act (Medizinregistergesetz), introducing a uniform legal framework for medical r...

Danish engineer wants to modernize the Nordic region’s biobanks

Biological samples are destroyed, lost and affected by temperature fluctuations more often than many people realize, according to German-Danish engineer Hans-Ch...

We’re heading to SCANDEM

ZEISS will be at SCANDEM 2026, the Annual Meeting of the Nordic Microscopy Society, June 9–12, in Oulu.

Precision FIB-SEM with live endpoint control for confident, repeatable workflows

ZEISS Crossbeam 750 FIB-SEM.

PMS, Vigilance and Risk Management

Post-Market Surveillance (PMS) is more than complaint handling – it’s a strategic tool for patient safety, regulatory compliance, and continuous improvement. Un...

ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens

The new intraocular lens combines an aspheric bitoric optic with a patented non-constant aberration design (ZO optic) on a fully preloaded, hydrophobic c-Loop p...

World’s highest resolution X-ray microscope

ZEISS VersaXRM 730.

Unlocking Predictive Insights for Drug Discovery and Development

3D tissue models webinar series.

Any Image Size, Many Formats, AI-Powered

ZEISS arivis optimizes local server or cloud computation resources.

Mercodia AB